Fear of Coronavirus Disease 2019—An Emerging Cardiac Risk | Cardiology | JN Learning | AMA Ed Hub [Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.177.17. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

Fear of Coronavirus Disease 2019—An Emerging Cardiac Risk

Educational Objective
To understand how fear during COVID-19 is an emerging cardiac risk
1 Credit CME

We are in the midst of the coronavirus disease 2019 (COVID-19) pandemic and, as many clinicians across the globe, we are seeing firsthand the pain and death caused by COVID-19. While there are more than 300 clinical trials currently under way for this illness, there are as yet no specific therapies broadly accepted to decrease mortality. In response to dire predictions and a lack of effective treatments, authorities across the world continue to recommend a series of aggressive mitigation strategies to slow the spread of COVID-19. While early fears of widespread death and overwhelmed hospitals have played an important role in sounding the alarm about this pandemic and motivated important social distancing measures, these fears are also causing substantial harm. In this Viewpoint, using cardiac disease as an example, we explore the hazards associated both with the pandemic and initial response. We argue that clinicians’ ability to modulate fear—a sensitive but nonspecific response to threats—will be a major determinant of the magnitude of the pandemic’s effects.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Corresponding Author: Marvin A. Konstam, MD, Cardiovascular Center, Tufts Medical Center, Tufts University School of Medicine, 800 Washington St, PO Box 108, Boston, MA 02111 (mkonstam@tuftsmedicalcenter.org).

Published Online: July 22, 2020. doi:10.1001/jamacardio.2020.2890

Correction: This article was corrected on August 12, 2020, to fix an error in the text. The phrase “there are no specific therapies that are known to decrease mortality” should instead have said “there are as yet no specific therapies broadly accepted to decrease mortality.” The error has been corrected.

Conflict of Interest Disclosures: Dr Wessler reported support from the National Institutes of Health (grants K23AG055667 and R03AG056447) during the conduct of the study. Dr Kent reported support from the National Institutes of Health (grant UL1TR002544) and the Patient-Centered Outcomes Research Institute (grant ME-1606-35555). No other disclosures were reported.

References
1.
Grewelle  R , De Leo  G . Estimating the global infection fatality rate of COVID-19. Published May 18, 2020. Accessed June 15, 2020. https://www.medrxiv.org/content/10.1101/2020.05.11.20098780v1
2.
Wynants  L , Van Calster  B , Bonten  MMJ ,  et al.  Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal.   BMJ. 2020;369:m1328. doi:10.1136/bmj.m1328 PubMedGoogle ScholarCrossref
3.
Vickers  AJ , Kent  DM .  The Lake Wobegon effect: why most patients are at below-average risk.   Ann Intern Med. 2015;162(12):866-867. doi:10.7326/M14-2767 PubMedGoogle ScholarCrossref
4.
Garcia  S , Albaghdadi  MS , Meraj  PM ,  et al.  Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic.   J Am Coll Cardiol. 2020;75(22):2871-2872. doi:10.1016/j.jacc.2020.04.011PubMedGoogle ScholarCrossref
5.
Gautam  S , Menachem  J , Srivastav  SK , Delafontaine  P , Irimpen  A .  Effect of Hurricane Katrina on the incidence of acute coronary syndrome at a primary angioplasty center in New Orleans.   Disaster Med Public Health Prep. 2009;3(3):144-150. doi:10.1097/DMP.0b013e3181b9db91 PubMedGoogle ScholarCrossref
6.
Wong  SC-Y , Kwong  RT-S , Wu  TC ,  et al.  Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.   J Hosp Infect. 2020;105(2):119-127. doi:10.1016/j.jhin.2020.03.036 PubMedGoogle ScholarCrossref
7.
Law  MR , Watt  HC , Wald  NJ .  The underlying risk of death after myocardial infarction in the absence of treatment.   Arch Intern Med. 2002;162(21):2405-2410. doi:10.1001/archinte.162.21.2405PubMedGoogle ScholarCrossref
8.
Roe  MT , Messenger  JC , Weintraub  WS ,  et al.  Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention.   J Am Coll Cardiol. 2010;56(4):254-263. doi:10.1016/j.jacc.2010.05.008PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close